Wallenberg Centre for Molecular Medicine

Faculty of Medicine | Lund University

16/05/12 - Three tenure track research positions in WCMM Lund are now open for application

2016-05-12

Three tenure track research positions in Regenerative Medicine (Regeneration, Replacement and Repair) are now open in the following areas: Diabetes, the Respiratory System and the Hematopoietic System.

Welcome with your application – the deadline for submission is June 27, 2016.

Associate Senior Lecturer (Assistant Professor) in Molecular Medicine: Regeneration, Replacement, and Repair in Diabetes

Read more about our research in the field

Associate Senior Lecturer (Assistant Professor) in Molecular Medicine: Regeneration, Replacement, and Repair in the Respiratory System

Read more about our research in the field

Associate Senior Lecturer (Assistant Professor) in Molecular Medicine: Regeneration, Replacement, and Repair in the Hematopoietic System

Read more about our research in the field

In close integration with Skåne University Hospital, a clinical researcher will be part of each team. The clinical positions within each team will be advertised during autumn 2016. For further information, please see career packages at this homepage.

If you have any questions regarding the application process - please don't hesitate to contact us – see contacts 

Welcome with your application – the deadline for submission is June 27, 2016.


About our research in these fields

DIABETES:

Research on diabetes has become one of the most prominent research areas at Lund University. It has been supported by two major national center grants. No less than four of the PIs hold individual ERC grants. The signature field of Lund University Diabetes Centre (LUDC) is the genetics of Type 2 Diabetes, a field it has pioneered and is now steering towards a functional genomics approach with a strong translational element. Islet biology is also at the cutting edge of international diabetes research. LUDC has access to large patient cohorts and biobanks, which are unique in the world. Technical platforms for omics, imaging, transgenic models and profiling of plasma samples are available and there is a tight association with the clinical department. LUDC, which comprises approx. 400 scientists, is a vibrant research environment well-known for its interactive and generous atmosphere.

THE RESPIRATORY SYSTEM:

Chronic respiratory diseases are common diseases in modern society. Asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and bronchiolitis obliterans syndrome are all diseases that severely affect quality of life. The overarching aim for our research milieu is to identify optimal regenerative capacity by understanding key pathophysiological mechanisms in chronic inflammatory airway diseases, for use in phenotyping, predicting prognosis and evaluate response to therapy, but also to develop new cell therapies. To reach these goals we have built-up a translational research milieu in Lund for clinical- and experimental top research. In this milieu we have excellent clinicians, large biobanks, and experimental researchers working with tissue microarrays for cell patterns and extracellular matrix, cell culture platforms with cell sorting capacities, extracellular competence, mass spectrometry, and stem cell progenitors. We strongly believe that regenerative medicine has the potential to increase the preclinical knowledge of the pathophysiological mechanisms behind serious life shortening lung diseases ultimately identifying therapeutic cells for future therapy.

THE HEMATOPOIETIC SYSTEM:

The hematopoiesis research environment at Lund University has an internationally leading role. More than 20 independent research groups are currently working on various aspects of basic and translational hematological research and are physically co-localized across two neighboring floors providing a highly interactive and dynamic research environment. A major aim is to promote the development of improved cell-based therapies of hematological diseases. Examples of such research include developmental hematopoiesis and lineage specification, biology of hematopoietic stem cells and mesenchymal stroma cells, as well as ES/iPS cell and gene therapy applications. For more information see: www.med.lu.se/molmed and www.med.lu.se/dmh.

Site overview